Drugs / Anti-CD33/CLL1 CAR-NK Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05215015 | Nov 2020 → Nov 2022 | acute myeloid leukemia | Wuxi People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-CD33/CLL1 CAR-NK Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05215015 ↗ |
| Modality | Cell therapy | “CAR-NK cell injection” NCT05215015 ↗ |
| Target | CD33 | “Targeting CD33” NCT05215015 ↗ |